Insider: SCHEIBLER LUKAS Chief Research Officer - Apellis Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 68,299 | 0 | 68,299 |
| Value | $1,527,848.63 | $0.00 | $1,527,848.63 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 12/01/2023 | DDS | 10,000 | Direct | COM | $60.00 | $600,000.00 | 68,299 |
| 09/06/2023 | DDS | 1,756 | Direct | COM | $43.01 | $75,525.56 | 68,299 |
| 05/27/2022 | DDS | 10,000 | Direct | COM | $43.00 | $430,000.00 | 40,358 |
| 04/05/2022 | DDS | 609 | Direct | COM | $60.09 | $36,592.98 | 52,233 |
| 04/04/2022 | DDS | 1,437 | Direct | COM | $56.86 | $81,713.57 | 53,482 |
| 04/04/2022 | DDS | 818 | Direct | COM | $55.84 | $45,677.12 | 54,919 |
| 04/04/2022 | DDS | 1,249 | Direct | COM | $57.81 | $72,198.45 | 52,233 |
| 04/01/2022 | DDS | 11,496 | Direct | COM | $55.05 | $632,854.80 | 52,233 |
| 02/11/2022 | DDS | 1,666 | Direct | COM | $46.80 | $77,968.80 | 51,513 |
| 02/10/2022 | DDS | 10,000 | Direct | COM | $50.00 | $500,000.00 | 53,179 |
| 02/08/2022 | DDS | 10,000 | Direct | COM | $45.00 | $450,000.00 | 53,857 |
| 01/31/2022 | DDS | 1,233 | Direct | COM | $38.47 | $47,433.51 | 53,857 |
| 06/10/2021 | DDS | 3,417 | Direct | COM | $60.00 | $205,020.00 | 26,651 |
| 05/24/2018 | AAP | 2,935 | Direct | COM | $20.37 | $59,785.95 | 2,935 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research